PD-L1 expression can be investigated using different scoring methods in immunohistochemistry: it can be assessed on immune cells (IC) only, on tumour cells (TC) only or on both IC and TC, as in the Combined Positive Score (CPS). This evidence concerns the gene CD274 and neoplasm.